The Oscars of Science
Revolutionary advances in physics and chemistry used at Boehringer Ingelheim
Search
More Health: Overview
As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations.
Who we are
The Boehringer Ingelheim Regional Center Vienna (RCV for short) bears business responsibility for more than 30 countries in Central and Eastern Europe and Central Asia.
Schizophrenia in real life
Through these real-life stories, discover the eye-opening reality of life with schizophrenia.
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Open Innovation Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Veterinarians go above and (far) beyond.
Veterinarians go above and (far) beyond.
Boehringer Ingelheim Awards Innovation Prize to Ablevia
Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Patients in Focus
Boehringer Ingelheim RCV provides over six million patients with innovative therapies. Ensuring that the patients’ needs at every stage are met precisely is of decisive importance.